Platinum-Carborane Complexes as New Agents for Boron Neutron Capture Therapy

铂-碳硼烷配合物作为硼中子捕获疗法的新剂

• 批准号: DP0557118
• 负责人: Prof Louis Rendina
• 金额: $ 20.1万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2005
• 资助国家: 澳大利亚
• 起止时间: 2005-02-28 至 2008-11-21
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP0557118
• 关键词: Platinum; Carborane; Complexes; New; Agents

The development of new drugs and treatments for cancer is highly important to human health and the well-being of the community. This research has the potential to lead to new anticancer pharmaceuticals that will expand the clinical efficacy of current drugs and generate significant export income through future IP development and possible commercialization. The innovative nature of this research will also contribute to Australia's science knowledge base, a key element in its future economic prosperity, and it will provide excellent training of young researchers for employment in the rapidly expanding field of biotechnology.

癌症新药和治疗方法的开发对人类健康和社区福祉非常重要。 这项研究有可能产生新的抗癌药物，扩大现有药物的临床疗效，并通过未来的知识产权开发和可能的商业化产生可观的出口收入。 这项研究的创新性质也将有助于澳大利亚的科学知识基础，这是其未来经济繁荣的一个关键因素，它将为年轻研究人员提供良好的培训，以便在迅速扩大的生物技术领域就业。